Thought Leadership
Search results
Blog | July 07, 2015
Read more
FDA's Latest ANDA Guidance: Patent Carve Outs Become a Guessing Game
Pharmaceutical Compliance Monitor
Blog | July 06, 2015
35 U.S.C. § 101 Practice in the Eastern District of Texas
Fish & Richardson
Read more
Blog | July 03, 2015
DDE excludes revenues & profits due to failed apportionment, allows do-over
Fish & Richardson
Read more
Blog | July 02, 2015
Nevada court imposes 3X post-judgment royalty in lieu of injunction
Fish & Richardson
Read more
Blog | July 01, 2015
Utah court allows evidence of minimum royalty payments by third parties
Fish & Richardson
Read more
Blog | June 19, 2015
CDIL rejects defendants' EMVR and SSPPU arguments and allows royalty base on entire products
Fish & Richardson
Read more
Blog | June 18, 2015
Ordered Method Claim Does Not Bar Partly-Simultaneous Performance of Steps
Fish & Richardson
Read more
Blog | June 17, 2015
Claims Covering Basic Detection of Naturally-Occurring Compound, However Scientifically Significant, Not Patent Eligible
Fish & Richardson
Read more
Blog | June 17, 2015
PTAB Decision Highlights Little Used Claim Amendment Process in America Invents Act Patent Challenges
Fish & Richardson
Read more
Blog | June 12, 2015
Read more
Hatch-Waxman Actions: Who Do You (Can You) Sue?
Pharmaceutical Compliance Monitor
Blog | June 11, 2015
Use of Generic Computer Functions to Make Traditional Economic Method More Efficient Does Not Confer Patent Eligibility
Fish & Richardson
Read more